全文获取类型
收费全文 | 5881篇 |
免费 | 469篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 56篇 |
儿科学 | 158篇 |
妇产科学 | 158篇 |
基础医学 | 837篇 |
口腔科学 | 125篇 |
临床医学 | 550篇 |
内科学 | 1187篇 |
皮肤病学 | 96篇 |
神经病学 | 548篇 |
特种医学 | 256篇 |
外科学 | 626篇 |
综合类 | 135篇 |
一般理论 | 4篇 |
预防医学 | 657篇 |
眼科学 | 224篇 |
药学 | 369篇 |
中国医学 | 13篇 |
肿瘤学 | 377篇 |
出版年
2021年 | 98篇 |
2020年 | 51篇 |
2019年 | 84篇 |
2018年 | 96篇 |
2017年 | 71篇 |
2016年 | 71篇 |
2015年 | 77篇 |
2014年 | 117篇 |
2013年 | 185篇 |
2012年 | 240篇 |
2011年 | 281篇 |
2010年 | 169篇 |
2009年 | 165篇 |
2008年 | 228篇 |
2007年 | 251篇 |
2006年 | 269篇 |
2005年 | 281篇 |
2004年 | 287篇 |
2003年 | 275篇 |
2002年 | 239篇 |
2001年 | 166篇 |
2000年 | 168篇 |
1999年 | 159篇 |
1998年 | 91篇 |
1997年 | 77篇 |
1996年 | 68篇 |
1995年 | 72篇 |
1994年 | 72篇 |
1993年 | 66篇 |
1992年 | 113篇 |
1991年 | 121篇 |
1990年 | 110篇 |
1989年 | 100篇 |
1988年 | 105篇 |
1987年 | 104篇 |
1986年 | 102篇 |
1985年 | 78篇 |
1984年 | 69篇 |
1983年 | 59篇 |
1982年 | 61篇 |
1981年 | 50篇 |
1980年 | 66篇 |
1979年 | 58篇 |
1978年 | 67篇 |
1977年 | 61篇 |
1976年 | 53篇 |
1974年 | 55篇 |
1973年 | 49篇 |
1972年 | 40篇 |
1971年 | 34篇 |
排序方式: 共有6376条查询结果,搜索用时 15 毫秒
21.
22.
Shirley A. Musich Alyssa B. Schultz Wayne N. Burton Dee W. Edington 《Disease Management & Health Outcomes》2004,12(5):299-326
Corporations have engaged in sponsorship of health management programs and, more recently, disease management programs to facilitate healthy and productive work environments. The purpose of this review is to examine the health and financial outcomes from these corporate-sponsored disease management programs. This article focuses on seven diseases or chronic conditions (arthritis, asthma, cancer, depression, diabetes mellitus, heart disease, and migraine) that potentially impact employee productivity (both in time away from work and in loss of effectiveness at work) and health status including medical and pharmaceutical utilization and costs.Corporate-sponsored disease management programs typically focus on education and screening for selected diseases or chronic conditions. Partnerships have been formed with health plans and third-party program providers to reach employees with interventions and treatment. The typical outcome measures from these programs have primarily been clinical indicators and medical utilization. Measures of productivity need to be incorporated as important outcome measures for disease management programs.The estimated financial opportunity for the corporation is a reflection of the cost differential for a given disease and the prevalence of that disease within the employee population. Primary diseases, chronic conditions, and health risks contribute to increased medical utilization and decreased productivity within the corporation. Promoting programs that focus on the whole person, including health risks, chronic conditions, and diseases, will likely increase the possibility of success in helping the employee to better self-manage their health conditions and consequently provide gains for both the individual and the corporation. 相似文献
23.
24.
25.
Skeletal effects of calcitonin in ovariectomized rats 总被引:3,自引:0,他引:3
T J Wronski C F Yen K W Burton R C Mehta P S Newman E E Soltis P P DeLuca 《Endocrinology》1991,129(4):2246-2250
Although calcitonin (CT) has been shown to be effective for the prevention of bone loss in early postmenopausal women, the skeletal effects of the hormone specifically during the early stages of estrogen deficiency have not been characterized histomorphometrically to date. The current study involves use of the ovariectomized (OVX) rat as an animal model for early postmenopausal bone loss to perform such a histomorphometric analysis. One group of OVX rats was injected sc with salmon CT on alternate days for a 6-week period. Additional groups of OVX and sham-operated control rats were treated with vehicle alone. In comparison to control rats, the proximal tibia of vehicle-treated OVX rats were characterized by a 3-fold decrease in cancellous bone volume and significant increases in osteoblast surface (+200%), osteoclast surface (+143%), mineralizing surface (+111%), mineral apposition rate (+36%), bone formation rate (+181%), and longitudinal bone growth (+38%). In contrast, treatment of OVX rats with CT normalized tibial cancellous bone volume and significantly decreased all of the above cellular- and fluorochrome-based indices of bone turnover to near control levels. The results indicate that CT treatment depresses bone turnover and prevents the development of osteopenia in OVX rats. These findings are consistent with the bone protective effect of CT in early postmenopausal women and further support the OVX rat as an animal model for the preclinical evaluation of prophylactic treatments for postmenopausal bone loss. 相似文献
26.
27.
28.
29.
30.